◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DMAC

DiaMedica Therapeutics Inc. - (DMAC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NASDAQ · DATA UPDATED 2026-10-10

DiaMedica Therapeutics Inc. - (DMAC) operates in the NASDAQ industry and is headquartered in Minneapolis, United States with about 35 employees. Its market capitalization is roughly $499 million. In the fiscal year ended 2025-12-31, DMAC reported $0M in revenue and ($33M) in net income.

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Interactive charts & full statements →

DMAC Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	$0M	$0M
Gross Profit	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	$0M	$0M
Gross Margin %	—	—	—	—	—	—	—	—	100.0%	—	—	—	—	—	—	—	—	—	—	100.0%	100.0%
Operating Income (EBIT)	($39M)	($34M)	($27M)	($21M)	($14M)	($14M)	($13M)	($12M)	($7M)	($5M)	($2M)	($1M)	($5M)	($7M)	($10M)	($7M)	($4M)	($2M)	($2M)	($2M)	($1M)
Operating Margin %	138790.7%	—	—	—	—	—	—	—	-1352.2%	—	—	—	—	—	—	—	—	—	—	-1438.0%	-3058.7%
Net Income	($38M)	($33M)	($24M)	($19M)	($14M)	($14M)	($12M)	($11M)	($6M)	($4M)	($2M)	($1M)	($5M)	($7M)	($10M)	($7M)	($4M)	($2M)	($2M)	($2M)	($1M)
Net Margin %	134079.8%	—	—	—	—	—	—	—	-1146.8%	—	—	—	—	—	—	—	—	—	—	-1452.8%	-3023.0%
EBITDA	($37M)	($33M)	($24M)	($19M)	($14M)	($14M)	($13M)	($12M)	($6M)	($4M)	($2M)	($1M)	($5M)	($7M)	($8M)	($5M)	($3M)	($2M)	($2M)	($2M)	($1M)
Earnings Per Share (EPS)	$-0.73	$-0.70	$-0.60	$-0.60	$-0.52	$-0.65	$-0.78	$-0.89	$-0.74	$-0.72	$-0.47	$-0.25	$-1.55	$-2.71	$-4.11	$-2.93	$-2.98	$-2.54	$-2.04	$-2.91	$-0.89
Shares Outstanding (M)	54M	47M	40M	33M	26M	21M	16M	12M	8M	6M	5M	4M	3M	3M	2M	2M	1M	1M	1M	1M	1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMAC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$0M	$0M	$0M	$0M	$0M	$0M	$14M	$0M
Gross Profit	—	$0M	$0M	$0M	$0M	$0M	$0M	($7M)
Gross Margin %	—	—	50.0%	—	—	—	-0.1%	—
Operating Income (EBIT)	($10M)	($10M)	($9M)	($9M)	($8M)	($8M)	($8M)	($7M)
Operating Margin %	—	—	32904.8%	—	—	—	-61.0%	—
Net Income	($10M)	($10M)	($9M)	($9M)	($8M)	($8M)	($8M)	($6M)
Net Margin %	—	—	31215.4%	—	—	—	-57.2%	—
EBITDA	($10M)	($10M)	($9M)	($9M)	($8M)	($8M)	($8M)	($6M)
Earnings Per Share (EPS)	$-0.19	$-0.19	$-0.19	$-0.17	$-0.18	$-0.18	$-0.18	$-0.15
Shares Outstanding (M)	54M	54M	47M	50M	43M	43M	43M	43M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMAC Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	($32M)	($29M)	($22M)	($19M)	($12M)	($12M)	($9M)	($9M)	($6M)	($4M)	($3M)	($1M)	($4M)	($6M)	($5M)	($3M)	($2M)	($2M)	($1M)	($1M)	($1M)
Capital Expenditures (CapEx)	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	($32M)	($29M)	($22M)	($19M)	($12M)	($12M)	($9M)	($9M)	($6M)	($4M)	($3M)	($1M)	($4M)	($6M)	($6M)	($4M)	($2M)	($2M)	($2M)	($2M)	($1M)
FCF Margin %	112857.8%	—	—	—	—	—	—	—	-1149.2%	—	—	—	—	—	—	—	—	—	—	-939.8%	-3536.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMAC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($8M)	($9M)	($8M)	($7M)	($8M)	($7M)	($6M)	($4M)
Capital Expenditures (CapEx)	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	($8M)	($9M)	($8M)	($7M)	($8M)	($7M)	($6M)	($4M)
FCF Margin %	—	—	27754.6%	—	—	—	-46.7%	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMAC Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$45M	$61M	$46M	$54M	$34M	$46M	$28M	$9M	$18M	$2M	$2M	$0M	$0M	$3M	$4M	$6M	$9M	$1M	$3M	$4M	$1M
Cash & Cash Equivalents	$5M	$16M	$3M	$5M	$5M	$5M	$7M	$4M	$17M	$1M	$2M	$0M	$0M	$3M	$2M	$3M	$3M	$1M	$2M	$4M	$0M
Total Liabilities	$7M	$5M	$6M	$3M	$3M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$0M	$1M	$0M	$0M	$0M	$0M
Total Debt (Short + Long-Term)	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$1M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$38M	$56M	$41M	$51M	$32M	$44M	$26M	$8M	$17M	$1M	$1M	($1M)	($2M)	$1M	$2M	$6M	$9M	$1M	$3M	$4M	$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMAC viewer.

Other Companies in Software & IT Services

ADAM · Adamas Trust, Inc. - — $517 million
JCH · JPMorgan Claverhouse Ord — £510 million
ITIC · Investors Title Company - — $504 million
WEYS · Weyco Group, Inc. - — $501 million
BRGE · BlackRock Greater Europe Ord — £498 million
PBAM · Private Bancorp of America, Inc. — $496 million
PANL · Pangaea Logistics Solutions Ltd. - — $496 million
JEMI · JPMorgan Emerging Markets Div Inc — £493 million

← DMAA All “D” companies DMAD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.